What's on?

Development of a bioartificial pancreas

25 Feb 2014 | By INSERM (Newsroom) | Europe

European consortium BIOSID have developed a bioartificial pancreas that can directly produce insulin in the bodies of patients with type 1 diabetes, which should be tested in humans by 2015. Trials will be conducted by the team led by Eric Renard, a researcher at Inserm Unit 661, “Institute for Functional Genomics,” at Montpellier University Hospital, and by the University of Oxford.

These contents could be interesting :

Researcher Contact

Eric Renard
CIC Montpellier Unité Inserm 661 « Institut de génomique fonctionnelle »
+33 (0)4 67 33 83 82

Press Contact